United Therapeutics (UTH) Q4 2025 Earnings Report
DE:UTH Q4 2025 EPS Results
- Actual EPS
- EUR 6.88
- Consensus EPS
- EUR 6.38
- Beat/Miss
- Beat by +EUR 0.51
- One Year Ago EPS
- EUR 5.53
DE:UTH Q4 2025 Revenue Results
- Actual Revenue
- EUR 706.53M
- Expected Revenue
- EUR 726.98M
- Beat/Miss
- Missed by -EUR 20.46M
- YoY Revenue Growth
- +7.38%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 02/25/2026
- Time
- Before Open
- Conference Call
- Wednesday, February 25, 2026
DE:UTH Upcoming Earnings
United Therapeutics's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q4 2025 Earnings Call Audio
DE:UTH Q4 2025 Earnings Call
0:00 / 0:00
Q4 2025 Earnings Slide Deck
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:UTH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q3) | 5.37- | 6.4 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | 6.146.50 | 5.73 | 13.42% (+0.77) | |
| May 06, 2026 | 2026 (Q1) | 6.265.20 | 5.93 | -12.22% (-0.72) | |
| Feb 25, 2026 | 2025 (Q4) | 6.386.88 | 5.53 | 24.39% (+1.35) | |
| Oct 29, 2025 | 2025 (Q3) | 6.546.40 | 5.71 | 12.05% (+0.69) | |
| Jul 30, 2025 | 2025 (Q2) | 6.525.73 | 5.23 | 9.57% (+0.50) | |
| Apr 30, 2025 | 2025 (Q1) | 5.995.93 | 5.52 | 7.46% (+0.41) | |
| Feb 26, 2025 | 2024 (Q4) | 5.725.53 | 3.9 | 41.97% (+1.64) | |
| Oct 30, 2024 | 2024 (Q3) | 5.835.71 | 4.81 | 18.77% (+0.90) | |
| Jul 31, 2024 | 2024 (Q2) | 5.825.23 | 4.69 | 11.64% (+0.55) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
